The Jinling Cohort
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age45-75
SponsorNanjing Shihejiyin Technology, Inc.
About this trial
The Jinling Cohort is a prospective, multicenter cohort study in which 15,000 eligible individuals aged 45-75 in Nanjing China will be enrolled.
Eligibility criteria
Qualifiers
None
Disqualifiers
Pregnant women;
Individuals who have history of cancer or current diagnosis of cancer;
Individuals who have organ transplant or prior non-autologous (allogeneic) bone marrow or stem cell transplant;
Individulas who have blood transfusion within 30 days prior to the blood draw;
Trial design
Treatments tested in this trial
- MERCURY test, health questionnaires and annual routine physical exams
Treatment groups
15,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov